Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

495 ARTÍCULOS , VIENDO DEL 346 AL 360

Contribution of TMS and rTMS in the Understanding of the Pathophysiology and in the Treatment of Dystonia

Lozeron P, Poujois A, Richard A, Masmoudi S, Meppiel E, Woimant F, Kubis N.

Front Neural Circuits. 2016 Nov 10;10:90. doi: 10.3389/fncir.2016.00090. eCollection 2016.

Understanding dystonia: diagnostic issues and how to overcome them

Camargos S, Cardoso F.

Arq Neuropsiquiatr. 2016 Nov;74(11):921-936. doi: 10.1590/0004-282X20160140.

History of Botulinum Toxin Treatment in Movement Disorders

Jabbari B.

Tremor Other Hyperkinet Mov (N Y). 2016 Nov 28;6:394. doi: 10.7916/D81836S1. eCollection 2016.

Paroxysmal Nonepileptic Events in Glut1 Deficiency

Klepper J, Leiendecker B, Eltze C, Heussinger N.

Mov Disord Clin Pract. 2016 Nov-Dec;3(6):607-610. doi: 10.1002/mdc3.12387. Epub 2016 Jul 8.

Therapeutic Perspective on Tardive Syndrome with Special Reference to Deep Brain Stimulation

Morigaki R, Mure H, Kaji R, Nagahiro S, Goto S.

Front Psychiatry. 2016 Dec 26;7:207. doi: 10.3389/fpsyt.2016.00207. eCollection 2016.

A practical approach to the patient presenting with dropped head

Cauchi M, Marsh E.

Pract Neurol. 2016 Dec;16(6):445-451. doi: 10.1136/practneurol-2016-001450.

Multifocal myoclonus as a heralding manifestation of Wilson disease

Verma R, Holla VV, Pandey S, Rizvi I.

J Pediatr Neurosci. 2016 Oct-Dec;11(4):358-360. doi: 10.4103/1817-1745.199468.

Management of oromandibular dystonia on a chorea acanthocytosis: a brief review of the literature and a clinical case

Ortega MC, Skármeta NP, Diaz YJ.

Cranio. 2016 Sep;34(5):332-7. doi: 10.1179/2151090315Y.0000000027. Epub 2016 Apr 11.

Seizures as presenting and prominent symptom in chorea-acanthocytosis with c.2343del VPS13A gene mutation

Benninger F, Afawi Z, Korczyn AD, Oliver KL, Pendziwiat M, Nakamura M, Sano A, Helbig I, Berkovic SF, Blatt I.

Epilepsia. 2016 Apr;57(4):549-56. doi: 10.1111/epi.13318. Epub 2016 Jan 27.

A Rare Case of Psychomotor Disturbances Linked to the Use of an Adulterated Dietary Supplement Containing Sibutramine

Shapira B, Goldstein L, Reshef A, Poperno A.

Clin Neuropharmacol. 2016 May-Jun;39(3):154-6. doi: 10.1097/WNF.0000000000000141.

New onset progressive chorea with elevated striational antibody titers

Battista J, Tse W.

Parkinsonism Relat Disord. 2016 Mar;24:139-40. doi: 10.1016/j.parkreldis.2016.01.013. Epub 2016 Jan 14.

The HTT CAG-Expansion Mutation Determines Age at Death but Not Disease Duration in Huntington Disease

Keum JW, Shin A, Gillis T, Mysore JS, Abu Elneel K, Lucente D, Hadzi T, Holmans P, Jones L, Orth M, Kwak S, MacDonald ME, Gusella JF, Lee JM.

Am J Hum Genet. 2016 Feb 4;98(2):287-98. doi: 10.1016/j.ajhg.2015.12.018.

Cannabinoid pharmacology in cancer research: A new hope for cancer patients?

Javid FA, Phillips RM, Afshinjavid S, Verde R, Ligresti A.

Eur J Pharmacol. 2016 Mar 15;775:1-14. doi: 10.1016/j.ejphar.2016.02.010. Epub 2016 Feb 5.

Paraneoplastic Choreoathetosis in a Patient with Small Cell Lung Carcinoma and Anti-CRMP5/CV2: A Case Report

Aydin D, Somnier F, Lassen LH.

Case Rep Neurol. 2016 Jan 8;8(1):16-9. doi: 10.1159/000443522. eCollection 2016 Jan-Apr.

Parkinsonism, movement disorders and genetics in frontotemporal dementia

Baizabal-Carvallo JF, Jankovic J.

Nat Rev Neurol. 2016 Mar;12(3):175-85. doi: 10.1038/nrneurol.2016.14. Epub 2016 Feb 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias